Skip to main content

Bruker Shares Rebound, Stratagene Shares Fall Again

Shares of Bruker Biosciences gained 13.4 percent for the trading week ended Tuesday, reversing a 7-percent decline the week before. The firm led the seven companies in the BCW Index that gained ground for the tracking period. Stratagene led decliners in the Index with a drop of 9.3 percent. Its shares reached a 52-week low of $5.51 on Tuesday before closing at $5.67.

Overall, the Index gained .1 percent for the week. In comparison, the Dow Jones Industrial Average fell .5 percent, the Nasdaq dropped .3 percent, and the Nasdaq Biotech Index declined .7 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(June 27, 2006)
Last Price
(June 20, 2006)
% change
Agilent
A
30.44
32.18
-5.4
Applied Biosystems
ABI
32.15
30.50
5.4
Beckman
BEC
53.43
53.44
0.0
Bio-Rad
BIO
64.35
64.80
-0.7
Bruker
BRKR
5.24
4.62
13.4
Fisher Scientific
FSH
69.27
70.29
-1.5
GE
GE
32.88
33.70
-2.4
Harvard Bio
HBIO
4.31
4.09
5.4
Invitrogen
IVGN
64.89
64.19
1.1
Molecular Devices
MDCC
29.45
28.42
3.6
PerkinElmer
PKI
20.35
20.40
-0.2
Qiagen
QGEN
12.89
13.20
-2.3
Sigma
SIAL
70.70
70.03
1.0
Stratagene
STGN
5.67
6.25
-9.3
Thermo
TMO
34.03
34.82
-2.3
Waters
WAT
43.19
41.66
3.7
BCW Index Average
35.83
35.79
0.1
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.